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Background: Employment rates among those with chronic obstructive pulmonary disease 
(COPD) are lower than those without COPD, but little is known about the factors that affect 
COPD patients’ ability to work.
Methods: Multivariable analysis of the Birmingham COPD Cohort Study baseline data was 
used to assess the associations between lifestyle, clinical, and occupational characteristics and 
likelihood of being in paid employment among working-age COPD patients.
Results: In total, 608 of 1,889 COPD participants were of working age, of whom 248 (40.8%) 
were in work. Older age (60–64 years vs 30–49 years: odds ratio [OR] =0.28; 95% confidence 
interval [CI] =0.12–0.65), lower educational level (no formal qualification vs degree/higher 
level: OR =0.43; 95% CI =0.19–0.97), poorer prognostic score (highest vs lowest quartile of 
modified body mass index, airflow obstruction, dyspnea, and exercise (BODE) score: OR =0.10; 
95% CI =0.03–0.33), and history of high occupational exposure to vapors, gases, dusts, or fumes 
(VGDF; high VGDF vs no VGDF exposure: OR =0.32; 95% CI =0.12–0.85) were associated 
with a lower probability of being employed. Only the degree of breathlessness of BODE was 
significantly associated with employment.
Conclusion: This is the first study to comprehensively assess the characteristics associated 
with employment in a community sample of people with COPD. Future interventions should 
focus on managing breathlessness and reducing occupational exposures to VGDF to improve 
the work capability among those with COPD.
Keywords: chronic obstructive pulmonary disease, work, employed, breathlessness, severity, 
VGDF, UK
Introduction
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease 
characterized by airflow obstruction.1 It affects 6%–10% of the global population2 and 
is an important cause of morbidity and mortality worldwide.3,4 In 2003, an estimated 
44% of the UK COPD population were of working age, of whom around one-quarter 
were not in work due to their COPD.5 These estimates are higher in the USA, where 
69.0% of the people with COPD are of working age,6 and more than one-third are 
not working due to their COPD.7 Furthermore, there is consistent evidence across a 
range of observational studies8–13 and a review14 that patients with COPD have lower 
employment rates than those without COPD, and they are also less likely to be in work 
compared to people with asthma or those with other chronic diseases.8 Likewise, there 
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is some evidence to suggest that when out of work, COPD 
patients are less likely to reenter the labor market compared 
to those with no chronic conditions.8 Estimates from US 
data suggest that COPD-attributed work loss costs the US 
economy $18.5 billion annually.14 
There is increasing evidence that being in work is good for 
physical and mental health and well-being.15 There are also 
economic advantages for both the individual and society. Thus, 
interventions to support people with chronic diseases to remain 
in or return to work are recommended.16,17 However, a better 
understanding of the disease-related aspects that affect employ-
ment is needed to inform the planning of such interventions.
Few studies have examined the factors associated with 
employment among patients with COPD, and although a range 
of behavioral and disease-related factors are implicated, the 
findings are inconsistent. Although current smoking, severity 
of airflow obstruction, degree of symptoms, and the number 
and type of comorbidities have been shown to be associated 
with lower employment rates,11,18,19 other studies have not con-
firmed this.13,20 Occupational exposures may also contribute 
to the lower employment rates among those with COPD,19 
although evidence for this is also limited and conflicting.19,20 
Furthermore, methodological weakness, including lack of 
adjustment for important confounders and use of self-report 
as a measure of COPD status, limits interpretation. In addi-
tion, most of the previous studies have been based in the USA, 
Nordic countries, and the Netherlands, which have different 
social and welfare settings compared to the UK, potentially 
impacting the motivation to remain in work. Therefore, in 
this study, baseline data from the Birmingham COPD Cohort 
Study in the UK were used to assess the factors associated with 
employment among people with COPD in the community.
Methods
study design and participants
Participants with COPD from the Birmingham COPD Cohort 
Study were included in the present study.21 Patients on primary 
care COPD registers and those who were newly diagnosed with 
COPD through a case-finding trial22 were recruited between 
June 2012 and July 2014, from 71 general practices within 
the West Midlands, UK. This analysis included only partici-
pants with COPD who were of working age (,65 years). All 
participants provided written informed consent to take part in 
the Birmingham COPD Cohort Study.
ethical approval
The Birmingham COPD Cohort Study is part of The 
Birmingham Lung Improvement StudieS (BLISS). As this 
was a cohort study, ethical approval was required from a 
national ethics committee. The Birmingham COPD Cohort 
received ethical approval from the National Research Ethics 
Service Committee West Midlands – Solihull (Reference: 
11/WM/0304).
Measures
As a part of the baseline assessment, all participants were 
asked to complete detailed questionnaires and underwent a 
range of clinical assessments. All these assessments were 
undertaken by trained research assistants (RAs), using 
standardized protocols and validated instruments.
sociodemographic characteristics and lifestyle
Validated questionnaires were used to collect information on 
age, sex, smoking status, highest educational level achieved, 
and gross household income. Social deprivation was mea-
sured by using the Index of Multiple Deprivation (IMD) 
2010 score23 based on individual participant postcodes.
Clinical characteristics
Relevant questionnaire items included breathlessness (the 
Medical Research Council [MRC] score),24 COPD specific 
quality of life measure (COPD Assessment Test [CAT]),25 
exacerbations (self-reported steroid or antibiotic treatment 
for an exacerbation in the previous 12 months), and comor-
bidities (self-reported physician diagnosis of cardiovascular 
disease, diabetes, gastrointestinal disease, cancer, depression, 
osteoarthritis, rheumatoid arthritis, hay fever, eczema, and 
allergies). Height (to the nearest 0.1 cm) and weight (to the 
nearest 0.1 kg) measurements were obtained and used to 
derive body mass index (BMI). Pre- and postbronchodilator 
spirometries, according to the American Thoracic Society/
European Respiratory Society 2005 guidelines,26 were car-
ried out by the RAs who received intense training based 
on a modified version of the Association for Respiratory 
Technology and Physiology spirometry course. The severity 
of airflow obstruction was determined by using postbroncho-
dilator spirometry; % predicted forced expiratory volume in 
1 s (FEV
1
; postbronchodilator) was calculated using Global 
Lung Function Initiative reference equations27 (% of the pre-
dicted values for the patients’ age, height, sex, and ethnicity, 
with reference to a healthy nonsmoking population), and 
Global Initiative for Chronic Obstructive Lung Disease 
(GOLD) staging criteria28 were used to measure the sever-
ity of airflow obstruction. The sit-to-stand test (counting the 
number of times the participant stood from a seated position, 
without using their arms to stand up) was used to assess 
exercise capacity (carried out postbronchodilator).29
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A multicomponent prognostic score (modified body mass 
index, airflow obstruction, dyspnea, and exercise [BODE] 
index) was calculated using the sit-to-stand test as a proxy 
for the 6-min walk test (6MWT) by using cutoff points 
derived from a study that assessed the correlation between 
the two measures.29
Occupational characteristics
Irrespective of the current employment status of the par-
ticipants who were included in the present study, trained 
RAs obtained detailed information about their occupational 
history through face-to-face interviews by using a validated 
questionnaire from the Work Employment Relations Study.30 
The trained RAs used this information to manually generate 
a 4-digit standard occupational classification (SOC) 2010 
code for the longest held occupation by using the Computer-
Assisted Structured Coding Tool (CASCOT) software.31
For accurate and standardized SOC coding, one of the 
authors (KKR) delivered a standardized training program 
to all the RAs. The training program provided instructions 
on software navigation, the factors to consider when coding 
occupations (job title and job tasks), and practice sessions 
for coding a range of occupations. RAs were encouraged 
to contact KKR in the event of ambiguity (difficult to 
code occupations) for advice. A random sample of 25–30 
participants who were assessed by each RA was also 
interviewed by KKR, who independently generated the SOC 
code, and was blind to the code originally generated by the 
RA, for quality control. The RA’s code was overwritten when 
there were any discrepancies, and further training offered to 
the RA if required.
A job exposure matrix (JEM) derived from the airborne 
chemical exposure (ACE) JEM32 was used to assign the risk 
(ie, none, low, medium, and high) of occupational exposures 
to vapors, gases, dusts, or fumes (VGDF) for each SOC code. 
This was developed based on previous published work32 
(through personal communication between SSS and KKR). 
Self-reported employment type (employed for wages/self-
employed) was collected for a subset of participants.
Primary outcome
The primary outcome was employment. The participants were 
categorized as being employed if they reported any current 
paid employment (full-time or part-time) or as not employed 
if they reported no paid employment at the baseline visit.
statistical analyses
All the analyses were conducted by using STATA version 13.0. 
Multivariable logistic regression models were used to examine 
the associations between paid employment and sociodemo-
graphic, lifestyle, clinical, and occupational characteristics.
Univariate models were fitted with each characteristic 
separately, followed by the final multivariable model. Known 
clinically important covariates (ie, age, sex, smoking status, 
and number of comorbidities), clinical severity, and socio-
economic status were included in the multivariable model. 
The exact measures of clinical severity (ie, MRC score, CAT 
score, number of exacerbations, and modified BODE index) 
and socioeconomic status (ie, education level, income, and 
IMD score) used in the multivariable model were chosen 
by using the likelihood ratio test, based on which covari-
ate significantly contributed to the model (likelihood ratio 
P,0.05).
An additional model was fitted to further explore the 
importance of individual components of the BODE index, 
adjusting for age, sex, smoking status, education level, 
number of comorbidities, exposures to VGDF, and the other 
components of the modified BODE index.
In a subset of participants for whom data were available, 
the effect of employment type (employed/self-employed) on 
being in work was also assessed.
Results
Characteristics of the participants
Among 1,889 participants with COPD in the Birmingham 
COPD Cohort Study, there were 608 (32.2%) participants 
who were of working age and form the group that is 
studied, of whom 248 (40.8%) participants reported being 
in work (Figure 1).
Table 1 summarizes the characteristics of study partici-
pants. Around half (n=287; 47.2%) of the participants were 
aged 60–64 years, 278 (49.7%) participants were current 
smokers, 248 (51.5%) participants had no formal educational 
Figure 1 Participant flow chart for study participants from the Birmingham COPD 
Cohort study.
Note: *employment status data missing for one participant at the baseline visit.
????????????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f C
hr
on
ic 
O
bs
tru
ct
ive
 P
ul
m
on
ar
y 
Di
se
as
e 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
14
7.
18
8.
10
8.
17
9 
on
 0
2-
Fe
b-
20
17
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
International Journal of COPD 2017:12submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
236
rai et al
Table 1 sociodemographic, lifestyle, clinical, and occupational characteristics of COPD patients of working age recruited to the 
Birmingham COPD Cohort study
Participant characteristics Male, number (%); 
n=343
Female, number (%); 
n=265
Total number (%); 
n=608
Sociodemographic characteristics
age categories (years)
38–49 40 (11.7) 28 (10.6) 68 (11.2)
50–59 125 (36.4) 128 (48.3) 253 (41.6)
60–64 178 (51.9) 109 (41.1) 287 (47.2)
education level
Degree or higher level 33 (12.1) 25 (12.0) 58 (12.0)
a level/as level or equivalent 21 (7.7) 15 (7.2) 36 (7.5)
gCse, Cse, O level, or equivalent 73 (26.7) 67 (32.1) 140 (29.1)
No formal qualification 146 (53.5) 102 (48.8) 248 (51.5)
IMD score quintiles
1–2
Increasing deprivation
110 (32.4) 74 (27.9) 184 (30.4)
3 70 (20.6) 66 (24.9) 136 (22.5)
4–5 160 (47.1) 125 (47.2) 285 (47.1)
Lifestyle characteristics
smoking status
never smoked 23 (7.2) 19 (7.9) 42 (7.5)
ex-smoker 135 (42.5) 104 (43.2) 239 (42.8)
Current smoker 160 (50.3) 118 (49.0) 278 (49.7)
Clinical characteristics
MrC dyspnea grade
1
Increasing breathlessness
81 (24.8) 44 (17.2) 125 (21.4)
2 57 (17.4) 46 (18.0) 103 (17.8)
3 68 (20.8) 62 (24.2) 130 (22.3)
4–5 121 (37.0) 104 (40.6) 225 (38.6)
CaT score
low (high QOl)
Increasing symptom 
impact
40 (15.1) 26 (12.5) 66 (14.0)
Medium 102 (38.5) 72 (34.6) 174 (36.8)
high 87 (32.8) 79 (38.0) 166 (35.1)
Very high (poor QOl) 36 (13.6) 31 (14.9) 67 (14.2)
Degree of airflow obstruction (GOLD stage)a,b
Mild 91 (28.0) 84 (32.9) 175 (30.2)
Moderate 154 (47.4) 133 (52.2) 287 (49.5)
severe to very severe 80 (24.6) 38 (14.9) 118 (20.3)
exacerbations in the last 12 months
0 146 (47.7) 82 (33.7) 228 (41.5)
1–2 110 (36.0) 92 (37.9) 202 (36.8)
3+ 50 (16.3) 69 (28.4) 119 (21.7)
Modified BODE index score quartilesa
1
Increasing severity
103 (41.2) 82 (39.1) 185 (40.2)
2 72 (28.8) 57 (27.1) 129 (28.0)
3 46 (18.4) 49 (23.3) 95 (20.7)
4 29 (11.6) 22 (10.5) 51 (11.1)
number of comorbidities
0 64 (18.7) 25 (9.4) 89 (14.6)
1–2 140 (40.8) 110 (41.5) 250 (41.1)
3+ 139 (40.5) 130 (49.1) 269 (44.2)
Comorbidities
Cardiovascular disease 155 (51.0) 113 (46.9) 268 (49.2)
Depression 86 (28.1) 95 (38.8) 181 (32.9)
gastrointestinal disease 89 (27.2) 71 (28.4) 160 (27.7)
Osteoarthritis 42 (14.4) 47 (19.8) 89 (16.8)
Diabetes 46 (15.3) 27 (11.2) 73 (13.5)
rheumatoid arthritis 29 (10.0) 37 (15.5) 66 (12.5)
Cancer 18 (6.0) 25 (10.3) 43 (7.9)
(Continued)
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qualification, and 321 (54.3%) participants had a manual 
occupational background (ie, skilled trade, process/plant/
machine operatives, elementary). More than one-third of 
the participants were either obese or severely obese (n=205; 
35.3%), and the majority had at least one comorbidity 
(n=519; 85.3%). The main comorbidities included: cardio-
vascular disease (n=268; 49.2%), depression (n=181; 32.9%), 
and gastrointestinal disease (n=160; 27.7%). There was a 
range of severity of disease described by dyspnea, CAT score, 
modified BODE score, and airflow obstruction. One-third of 
the participants (n=197; 33.1%) had either medium or high 
occupational exposures to VGDF.
Although there were some differences in the character-
istics between men and women, the most notable were the 
differences in types of occupation. Men were also more likely 
to experience higher workplace exposures to VGDF in their 
longest held occupation.
Factors associated with the likelihood of 
being in paid employment
In the univariate analyses, participants who were female, 
older, current smokers, had a lower level of education, and a 
higher deprivation score were less likely to be in paid employ-
ment (although not all the differences were statistically 
significant). In addition, participants with cardiovascular 
disease, diabetes, gastrointestinal disease, osteoarthritis, 
rheumatoid arthritis, and a greater number of comorbidities 
were less likely to be in work. 
A greater number of exacerbations, more severe breath-
lessness, higher CAT score, greater airflow obstruction, 
poorer prognostic score, and a history of higher VGDF 
exposure were also associated with lower probability of 
being in paid employment.
In the multivariable model, age, education level, modified 
BODE index, and occupational exposures to VGDF remained 
independently associated with employment status (Table 2). 
Women were less likely to be in work compared with men, 
although this did not reach statistical significance.
relationship between components of the 
BODe index and likelihood of being in 
paid employment
Table 3 shows the relative effects of the different compo-
nents of the BODE index. The present study found that 
Table 1 (Continued)
Participant characteristics Male, number (%); 
n=343
Female, number (%); 
n=265
Total number (%); 
n=608
BMI categories
Underweight (,18.5) 8 (2.5) 8 (3.1) 16 (2.8)
normal (18.5–24.9) 83 (25.5) 73 (28.4) 156 (26.8)
Overweight (25–29) 132 (40.6) 73 (28.4) 205 (35.2)
Obese (30–39.0) 96 (29.5) 76 (29.6) 172 (29.6)
severe obesity ($40.0) 6 (1.9) 27 (10.5) 33 (5.7)
Mean sit-to-stand repetitions (sD) 20.8 (6.6) 19.8 (6.6) 20.4 (6.6)
Occupational characteristics
Occupational background (sOC 2010)
Managers, directors, and senior officials 20 (5.9) 17 (6.6) 37 (6.2)
Professional 27 (8.0) 28 (10.9) 55 (9.2)
associate professional and technical 28 (8.3) 11 (4.3) 39 (6.5)
administrative and secretarial 5 (1.5) 48 (18.7) 53 (8.9)
skilled trade 116 (34.2) 12 (4.7) 128 (21.5)
Caring, leisure, and other services 7 (2.1) 38 (14.8) 45 (7.6)
sales and customer service 7 (2.1) 21 (8.2) 28 (4.7)
Process, plant, and machine operatives 87 (25.7) 39 (15.2) 126 (21.1)
elementary 42 (12.4) 43 (16.7) 85 (14.3)
exposures to VgDF in longest held job
none
Increasing occupational  
airborne exposure
65 (19.2) 129 (50.4) 194 (32.6)
low 129 (38.1) 73 (28.5) 202 (34.0)
Medium 78 (23.0) 49 (19.1) 127 (21.3)
high 67 (19.8) 5 (2.0) 72 (12.1)
Notes: aAirflow obstruction based on postbronchodilator FEV1 % predicted (mild: FeV1 $80% predicted; moderate: 50% # FeV1 ,80% predicted; severe: 30% # FeV1 ,50% 
predicted, and very severe: FeV1 ,30% predicted); 
bIncludes 94 participants (male: n=38 and female: n=56) who did not have airflow obstruction on the day of assessment. 
Total numbers may differ due to some missing data.
Abbreviations: BMI, body mass index; BODE, body mass index, airflow obstruction, dyspnea, and exercise; CAT, COPD Assessment Test; COPD, chronic obstructive 
pulmonary disease; FeV1, forced expiratory volume in 1 s; gOlD, global Initiative for Chronic Obstructive lung Disease; IMD, index of multiple deprivation; MrC, Medical 
Research Council; QOL, quality of life; SD, standard deviation; SOC, standard occupational classification; VGDF, vapors, gases, dusts, or fumes.
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Table 2 relationship between sociodemographic, lifestyle, clinical, and occupational characteristics and being in paid employment 
among working-age COPD patients
Characteristics Number (%) employed
n=248
Univariate model ORs  
(95% CI) for being employed
Final multivariable model ORs 
(95% CI) for being employeda
sex
Male 147 (42.9) 1.0 1.0
Female 101 (38.3) 0.83 (0.60–1.15) 0.60 (0.36–1.01)
age categories (years)
38–49 38 (55.9) 1.0 1.0
50–59 122 (48.4) 0.74 (0.43–1.27) 0.55 (0.24–1.26)
60–64 88 (30.7) 0.35 (0.20–0.60) 0.28 (0.12–0.65)
education level
Degree or higher level 40 (69.0) 1.0 1.0
a level/as level or equivalent 21 (58.3) 0.63 (0.27–1.50) 0.65 (0.23–1.90)
gCse, Cse, O level, or equivalent 64 (45.7) 0.38 (0.20–0.72) 0.55 (0.25–1.25)
No formal qualification 68 (27.5) 0.17 (0.09–0.32) 0.43 (0.19–0.97)
smoking status
never smoked 19 (45.2) 1.0 1.0
ex-smoker 103 (43.1) 0.92 (0.47–1.78) 0.98 (0.37–2.60)
Current smoker 106 (38.3) 0.75 (0.39–1.44) 0.79 (0.29–2.10)
number of comorbidities
0 44 (50.0) 1.0 1.0
1–2 118 (47.2) 0.89 (0.55–1.45) 1.14 (0.52–2.49)
3+ 86 (32.0) 0.47 (0.29–0.77) 0.70 (0.32–1.57)
MrC dyspnea grade
1
Increasing breathlessness
79 (63.2) 1.0
2 59 (57.3) 0.78 (0.46–1.33)
3 67 (51.5) 0.62 (0.38–1.02)
4–5 36 (16.0) 0.11 (0.07–0.18)
CaT score
low (high QOl)
Increasing 
symptom 
impact
42 (63.6) 1.0
Medium 88 (50.6) 0.58 (0.33–1.05)
high 52 (31.3) 0.26 (0.14–0.47)
Very high (poor QOl) 13 (19.7) 0.14 (0.06–0.31)
Degree of airflow obstructionb,c (gOlD stage)
Mild 91 (52.0) 1.0
Moderate 111 (38.7) 0.58 (0.40–0.85)
severe to very severe 38 (32.2) 0.44 (0.27–0.71)
exacerbations in the last 12 months
0 106 (46.5) 1.0
1–2 91 (45.1) 0.94 (0.65–1.38)
3+ 34 (28.6) 0.46 (0.29–0.74)
Modified BODE index score quartiles
1
Increasing severity
116 (62.7) 1.0 1.0
2 63 (48.8) 0.57 (0.36–0.90) 0.84 (0.48–1.47)
3 25 (26.3) 0.21 (0.12–0.37) 0.38 (0.19–0.74)
4 5 (9.8) 0.06 (0.02–0.17) 0.10 (0.03–0.33)
exposures to VgDF in longest held job
none
Increasing 
occupational 
airborne exposure
94 (48.0) 1.0 1.0
low 86 (42.6) 0.80 (0.54–1.19) 0.93 (0.51–1.71)
Medium 47 (37.9) 0.66 (0.42–1.05) 0.91 (0.43–1.91)
high 18 (24.7) 0.36 (0.19–0.65) 0.32 (0.12–0.85)
Notes: aMultivariable model includes age, sex, smoking status, education level, number of comorbidities, modified BODE index, and exposures to VGDF; bAirflow obstruction 
based on postbronchodilator FeV1 % predicted (mild: FeV1 $80% predicted; moderate: 50% # FeV1 ,80% predicted; severe: 30% # FeV1 ,50% predicted; and very severe: 
FeV1 ,30% predicted); 
cIncludes 94 participants (male: n=38; and female: n=56) who did not have airflow obstruction on the day of assessment. Total numbers may differ 
due to some missing data.
Abbreviations: BODE, body mass index, airflow obstruction, dyspnea, and exercise; CAT, COPD Assessment Test; CI, confidence interval; COPD, chronic obstructive 
pulmonary disease; FeV1, forced expiratory volume in 1 s; gOlD, global Initiative for Chronic Obstructive lung Disease; MrC, Medical research Council; Or, odds ratio; 
QOl, quality of life; VgDF, vapors, gases, dusts, or fumes.
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Factors associated with being in paid employment among people with COPD
only the dyspnea component significantly contributed to 
the overall model (likelihood ratio test, P,0.01) and was 
significantly independently associated with employment. 
In the adjusted models, the likelihood of being in paid 
employment was 64% lower for those with a modified 
MRC dyspnea score of 4, compared to those with a score of 
0–1 (adjusted odds ratio [OR] =0.36; 95% confidence inter-
val [CI] =0.15–0.85).
Point estimates of airflow obstruction and exercise 
capacity were suggestive of possible trends, but were not 
statistically significant. The BMI component within BODE 
was not associated with employment.
effect of employment type
Data on employment type were available from a subset of par-
ticipants (n=140; 23.0%). After adjustment, participants with a 
self-employed occupational background were more likely to be 
in work compared to those who were employed for wages (OR 
=3.84; 95% CI =0.55–26.88), although the CIs were wide.
Discussion
Key results
This is the first study in the UK to explore the association 
between sociodemographic, clinical, and occupational 
characteristics and the likelihood of being in paid employ-
ment among people with COPD. This study found that only 
40% of working-age COPD participants in the present cohort 
were in work, and the factors independently associated with 
the reduced probability of being in work were being older, 
having a lower educational level, worse breathlessness, and 
high occupational exposures to VGDF. 
Findings in relation to other studies
Compared with a recent UK labor force survey among a 
working-age population (16–64 years), the present COPD 
study sample had lower employment rates than the UK 
general population (employment rate 73.5%), those with 
a long-term health condition (59.6%), and those with a 
disability (46.1%).33 Although the age and sex structures of 
the populations may differ and partly account for these dif-
ferences, the findings are consistent with a previous work.8 
The finding from the present study that older age and 
lower levels of education were independently associated 
with reduced probability of employment is consistent with 
the findings of other published research among patients with 
COPD,13 and these are the well-recognized factors affect-
ing employment in the general population.34,35 Recent UK 
employment trends show that while there has been a rise 
in the proportion of women and a fall in the proportion of 
men who are now in work, employment rates among women 
remain lower than those among men.36 Smoking status has 
also been shown to be associated with employment status in 
the UK; those who are unemployed are nearly twice more 
likely to smoke.37 Although not statistically significant, the 
present findings suggested trends in the same direction for 
sex and smoking and may not have been clearly demonstrated 
due to the limited sample size. 
It was surprising to find that the presence of multiple 
comorbidities was not independently associated with 
the likelihood of employment; especially as in the univariate 
analyses, it appeared to be an important factor. Although this 
finding is consistent with those reported in other studies on 
patients with COPD,13,20 the direction of the point estimates 
and width of the CIs suggest that multiple comorbidities may 
be an important factor affecting employment, which might 
also be clarified with a larger sample. 
This seems to be the first study to use a standardized 
measure of exposure to VGDF (the ACE JEM32) within a 
model assessing the factors associated with employment sta-
tus among COPD patients. Previous research methods have 
used self-report19 and professional judgment20 as measures 
of determining these workplace exposures. This variation in 
Table 3 Relationship between the components of the modified 
BODe index and likelihood of being in paid employment
The BODE index 
components
Unadjusted 
OR (95% CI)
Adjusted ORa 
(95% CI)
P-value
B: BMI
.21 1.0 (reference) 1.0 (reference)
#21 0.83 (0.46–1.50) 0.80 (0.33–1.92) 0.61
O: Airflow obstruction (postbronchodilator FEV1 % predicted)
$65 1.0 (reference) 1.0 (reference) P for trend =0.60
50–65 0.63 (0.40–0.98) 0.95 (0.47–1.89)
35–49 0.61 (0.37–1.01) 0.83 (0.39–1.77)
#35 0.45 (0.21–0.95) 0.82 (0.25–2.71)
D: Dyspnea (mMrC score)
0–1 1.0 (reference) 1.0 (reference) P for trend ,0.01
2 0.69 (0.45–1.07) 1.18 (0.64–2.18)
3 0.14 (0.08–0.26) 0.23 (0.08–0.62)
4 0.11 (0.06–0.19) 0.36 (0.15–0.85)
E: Exercise capacity (modified to using sit-to-stand repetitions)
$26 1.0 (reference) 1.0 (reference) P for trend =0.09
21–25 0.71 (0.41–1.25) 0.84 (0.40–1.77)
16–20 0.36 (0.21–0.62) 0.80 (0.38–1.71)
#15 0.13 (0.07–0.24) 0.41 (0.16–1.03)
Note: aadjusted for age, sex, smoking status, education level, number of comorbidities, 
exposures to VGDF, and the other components of the modified BODE index.
Abbreviations: BMI, body mass index; BODE, body mass index, airflow obstruction, 
dyspnea, and exercise; CI, confidence interval; COPD, chronic obstructive pulmonary 
disease; FeV1, forced expiratory volume in 1 s; mMRC, modified Medical Research 
Council; Or, odds ratio; VgDF, vapors, gases, dusts, or fumes.
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measurement may lend some explanation for the conflicting 
results of the role of occupational exposures in employment 
among COPD patients.19,20 It is also worth noting that this 
study was based within the West Midlands, UK, an area that 
has a history of industrial occupations, where the likelihood 
of workplace exposures to VGDF may be higher than other 
areas within the UK. Although this may affect the prevalence 
estimates observed in the present study, the associations 
between high exposures to VGDF and the lower probability 
of being in work remain valid.
An interesting finding was that, of the several clinical 
factors related to disease severity, only the level of dyspnea 
was independently associated with employment and contrib-
uted to the final model. The other measures of disease severity 
within the composite BODE index – airflow obstruction and 
exercise capacity – were less important. However, although 
not statistically significant, they did indicate weaker trends, 
and a larger sample size may have increased the precision 
of the results.
Findings from the previous studies have revealed con-
flicting results between the association of airflow obstruction 
and employment status.11,13,19,20 These differences may be 
explained by the methodological differences between the 
studies as well as the measurement used to describe disease 
severity (eg, by using GOLD staging or mean FEV
1
 % pre-
dicted). There has been little work assessing the impact of 
other measures of disease severity, including the degree of 
breathlessness or other symptoms, on the ability to work.
Currently, it is accepted that airflow obstruction does not 
fully capture the impact of COPD on patients’ lives,38,39 and 
this study confirms that symptoms are more important in 
explaining whether a patient is in paid employment.
strengths and limitations
As this is a cross-sectional study, it was not possible to 
determine causality. Factors such as income, deprivation, and 
quality of life were significantly associated with employment 
in the univariate analyses. However, these are particularly 
susceptible to reverse causation and therefore were not 
included in the multivariable models. Workplace exposures 
to VGDF may also have preceded COPD diagnosis and 
may be an important factor in the development of COPD. 
Some data were based on self-report, including number of 
comorbidities and exacerbations, possibly introducing errors 
in prevalence rates and diluting the findings. In addition, there 
was a low response rate for some measures (eg, smoking 
status, exercise capacity, and exacerbations), which may 
have led to less reliable estimates. Due to low participation 
in the Birmingham COPD Cohort Study, the study sample 
may not be representative of the full range of patients with 
COPD in primary care. However, the associations observed 
remain valid. While there are a number of established and 
validated job exposure matrices available, the present study 
used the ACE JEM because it is the only matrix based on 
the UK occupational classification codes (SOC), allowing 
the data set to be easily merged and analyzed. Furthermore, 
it is the only JEM with a clear and detailed methodology, 
with estimates based on a comprehensive range of airborne 
occupational exposures. For the BODE prognostic index, a 
modified version was used – replacing the 6MWT with the 
sit-to-stand test as a measure of exercise capacity, and this 
requires further validation.
Implications for practice and research
The findings from the present study reveal some important 
differences among patients with COPD who are in paid 
employment compared to those who are not in paid employ-
ment, suggesting that there are possible opportunities to 
modify certain factors to improve work capability. Breath-
lessness was the most important clinical factor identified. 
The UK National Institute for Health and Care Excellence 
guidelines for COPD1 provide guidance for health care pro-
fessionals on the management of breathlessness. This may 
involve providing advice on better medication management 
(eg, the correct inhaler usage), advice on smoking cessation 
and referral to pulmonary rehabilitation (eg, among those 
who have a MRC score $3), or self-management advice. 
Therefore, health care professionals have a role to work 
alongside patients and focus on improving the management 
of their breathlessness, in particular among the working-
age population. Within the workplace, patients (alone or 
in conjunction with their employer) may want to consider 
modifying aspects of their job, which may otherwise exac-
erbate their breathlessness, for example, carrying heavy 
loads, regular use of stairs, or tasks that involve lifting 
and bending. 
The second important modifiable factor identified was 
high exposure to VGDF. This suggests that COPD patients 
should potentially undergo an occupational health (OH) 
assessment to determine the level of exposure to VGDF 
in their working environment and, thus, for OH services 
to advise accordingly on how those in high exposure jobs 
may be able to modify their job role, job tasks, or working 
environment.
Although being in work is associated with better health 
among patients with COPD, there is a need for prospective 
longitudinal studies to establish the temporal relation-
ships between disease severity, occupational exposures to 
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VGDF, and employment. Further research is also required 
to determine the effectiveness of managing breathlessness 
and reducing workplace exposures on work capability among 
patients with COPD.
Conclusion
This study demonstrates the high levels of unemployment 
among those with COPD. Two potentially modifiable fac-
tors associated with the reduced probability of being in work 
were identified: greater breathlessness and high workplace 
exposures to VGDF. Future interventions should focus on 
improving the management of breathlessness and reducing 
workplace exposures to VGDF in order to help improve the 
work capability in those with COPD.
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